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The structure of human 5′-deoxy-5′-methylthioadenosine
phosphorylase at 1.7 Å resolution provides insights into
substrate binding and catalysis
Todd C Appleby1, Mark D Erion2 and Steven E Ealick3*
Background: 5′-Deoxy-5′-methylthioadenosine phosphorylase (MTAP)
catalyzes the reversible phosphorolysis of 5′-deoxy-5′-methylthioadenosine
(MTA) to adenine and 5-methylthio-D-ribose-1-phosphate. MTA is a by-product
of polyamine biosynthesis, which is essential for cell growth and proliferation.
This salvage reaction is the principle source of free adenine in human cells.
Because of its importance in coupling the purine salvage pathway to polyamine
biosynthesis MTAP is a potential chemotherapeutic target.
Results: We have determined the crystal structure of MTAP at 1.7 Å resolution
using multiwavelength anomalous diffraction phasing techniques. MTAP is a
trimer comprised of three identical subunits. Each subunit consists of a single
α/β domain containing a central eight-stranded mixed β sheet, a smaller five-
stranded mixed β sheet and six α helices. The native structure revealed the
presence of an adenine molecule in the purine-binding site. The structure of
MTAP with methylthioadenosine and sulfate ion soaked into the active site was
also determined using diffraction data to 1.7 Å resolution.
Conclusions: The overall quaternary structure and subunit topology of MTAP are
similar to mammalian purine nucleoside phosphorylase (PNP). The structures of
the MTAP–ligand complexes provide a map of the active site and suggest
possible roles for specific residues in substrate binding and catalysis. Residues
accounting for the differences in substrate specificity between MTAP and PNP
are also identified. Detailed information about the structure and chemical nature
of the MTAP active site will aid in the rational design of inhibitors of this potential
chemotherapeutic target. The MTAP structure represents the first structure of a
mammalian PNP that is specific for 6-aminopurines.
Introduction
Human 5′-deoxy-5′-methylthioadenosine phosphorylase
(MTAP; EC 2.4.2.28) functions in the purine salvage
pathway where it catalyzes the reversible phosphorolysis
of 5′-deoxy-5′-methylthioadenosine (MTA), a 6-amino-
purine nucleoside formed during polyamine biosynthesis
[1]. The products of the reaction are free adenine and
5-methylthio-D-ribose-1-phosphate (MTR-1-P). Adenine
is subsequently recycled back into nucleotides through
the action of phosphoribosyltransferases [2], while MTR-
1-P is utilized in methionine biosynthesis [3]. MTAP
activity is responsible for essentially all of the free
adenine generated in human cells [4], indicating that this
enzyme performs an important function in the purine
salvage pathway.
MTAP activity was first characterized in rat ventral
prostate in 1969 [5]. The enzyme has since been purified
from a number of organisms and tissues including
the thermophilic bacterium Caldariella acidophila [6],
mouse Ascites sarcoma 180 cells [2], human placenta [7], 
Trypanosoma brucei brucei [8], bovine liver [9] and human
liver [10]. Biochemical evidence suggests that mam-
malian MTAP is a trimer made up of three identical sub-
units of 32 kDa [7,9], although in at least one case the
enzyme was reported as a dimer [10]. Each subunit in the
human enzyme contains 283 amino acid residues. Protein
sequence analysis reveals that human MTAP shares
25–28% identity with members of the mammalian purine
nucleoside phosphorylase (PNP) family of trimeric
enzymes. PNP also functions in the purine salvage
pathway where it catalyzes the phosphate-dependent
cleavage of nucleosides [11]. In mammals, PNP is
responsible for the phosphorolysis of the 6-oxopurine
nucleosides, guanosine and inosine, whereas MTAP is
highly specific for 6-aminopurine nucleoside substrates
[8,10]. In addition, human MTAP readily accepts
5′-deoxyadenosine and 6-aminopurine nucleosides con-
taining a halogen, haloalkyl or alkylthio group at the
5′ position of the sugar as substrates, but displays little or
no activity with adenosine or adenosine analogs contain-
ing a 5′-hydroxyl group [8,10,12].
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The crystal structures of PNP from human erythrocyte
[13] and bovine spleen [14] have been previously
reported, and extensive studies aimed at identifying
residues involved in substrate binding and catalysis have
been performed on the human enzyme [15–17]. Kinetic
studies of PNP mutants and structural studies of PNP
and PNP–ligand complexes identified active-site
residues that interact with the nucleoside and phosphate.
These studies suggested that Asn243 and Glu201 are
responsible for the high specificity of PNP for 6-oxo-
purines while His257 is believed to hydrogen bond to the
ribose moiety of the nucleoside in the sugar-binding
region. The phosphate-binding pocket of PNP contains
an arginine residue in addition to several polar
sidechains. The PNP studies also led to a proposed
enzyme mechanism: phosphorolysis is thought to
proceed through an SN1-type mechanism in which the
glycosidic bond is cleaved first, forming an oxocarbenium
ion intermediate that is stabilized and subsequently
attacked by one of the nucleophilic phosphate oxygens
[16]. Structural studies of human MTAP together with
structural comparisons to the functionally related mam-
malian PNP will help to establish a molecular basis for
the observed differences in substrate specificity between
the two enzymes and may offer insight into a possible
catalytic mechanism for MTAP.
In this report, we describe the 1.7 Å resolution crystal
structures of human MTAP bound to adenine alone and of
MTAP in complex with MTA and sulfate.
Results and discussion
Protein production and crystallization
Expression of the polyhistidine-tag–human-MTAP cDNA
construct in Escherichia coli BL21(DE3) cells [18] resulted in
the desired fusion protein (6His–MTAP) at levels approach-
ing 20% of the total soluble protein fraction from the host
cells (data not shown). After thrombin cleavage of the 6His-
tag, three residues from the tag remain fused to the natural
N-terminal end of MTAP (Gly-Ser-His-MTAP). The
resulting protein, however, is fully active indicating that the
additional residues do not disturb subunit–subunit interac-
tions or catalytic activity. Therefore, the proteolized recom-
binant product is considered equivalent to native human
MTAP. The final yield from the protein purification proce-
dure is 24 mg of purified material per liter of host cell
culture. Production of the selenomethionyl derivative of
MTAP (SeMet–MTAP) gave similar results to the native
enzyme, although the yield was about twofold lower. The
reduced yield is primarily accounted for by approximately
twofold lower expression of the 6His–MTAP construct in
the methionine auxotroph.
The optimized crystallization conditions for native MTAP
yield hexagonal rod-shaped crystals that grow in 12% (w/v)
polyethylene glycol (PEG) 6000, 25% (v/v) ethylene
glycol, 200 mM Tris-HCl pH 7.4 and 2 mM DTT and
obtain a maximum size of 0.4–0.5 mm in length and
0.2 mm in diameter across the hexagonal face. The crys-
tals belong to space group P321 with unit-cell constants of
a = b = 120.8 Å and c = 44.5 Å. The Matthews number
(VM) [19] is 3.0 Å3/Da assuming one monomer of molecu-
lar weight 31.2 kDa in the asymmetric unit, which corre-
sponds to a solvent content of ~59%. The 25% ethylene
glycol in the mother liquor also acts as a cryoprotectant,
allowing the MTAP crystals to freeze straight out of the
drop. These crystals diffract beyond 1.7 Å resolution when
using synchrotron radiation.
Although SeMet–MTAP was fully active, crystals failed
to grow under the native crystallization conditions. Explo-
ration of an expanded search grid around the native con-
ditions revealed that a substantial drop in reservoir pH (to
pH 5.9) and increased ionic strength were required for
growth of SeMet–MTAP crystals. Diffraction quality
crystals of SeMet–MTAP are long, thin hexagonal rods
that obtain a size of 0.5–0.6 mm in length and 0.1 mm in
diameter across the hexagonal face. These crystals also
belong to space group P321 with unit-cell constants of
a = b = 121.0 Å and c = 44.3 Å.
Structure determination
With one monomer containing 286 residues in the asym-
metric unit and nine selenomethionine residues per
monomer, the favorable ratio of roughly 32 residues per
Se atom suggested that the structure determination of
MTAP using multiwavelength anomalous diffraction
(MAD) phasing techniques was feasible [20]. A single,
frozen SeMet–MTAP crystal was used to collect a three-
wavelength MAD data set on beamline F2 at the Cornell
High Energy Synchrotron Source (CHESS). Although
technical considerations limited the data to 2.8 Å resolu-
tion, direct methods succeeded in finding eight out of the
nine selenium atom positions [21]. The missing Se atom
was later determined to belong to the N-terminal
selenomethionine residue that is believed to be disor-
dered along with ten other N-terminal residues that reside
in a solvent channel of the crystal. The resulting electron-
density map was of sufficient quality to trace most of the
polypeptide chain and model a majority of the backbone
and sidechain atoms.
A second MAD data set collected to significantly higher
resolution on beamline X12C at the National Synchrotron
Light Source (NSLS) was used together with the previ-
ously determined eight Se sites to calculate higher resolu-
tion experimental phases. This 2.2 Å resolution map
when solvent-flattened was of extremely high quality,
and allowed some previously missing residues to be
modeled. Figure 1 shows a representative region of the
electron-density map calculated from the 2.2 Å resolution
experimental MAD phases.
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Overall structure
The final model of MTAP consists of residues 9–224 and
230–281. The overall fold of MTAP is very similar to
mammalian PNP [13,14]. Figure 2 illustrates the structure
of the MTAP monomer, which consists of a single α/β
domain. The central portion of the molecule is made up of
a large eight-stranded mixed β sheet with topology β2, β3,
β4, β1, β5, β11, β6, β8. In addition, strands β5 and β11
extend into a smaller five-stranded mixed β sheet with
topology β7, β9, β10, β5, β11. The β sheets are flanked by
six α helices (Figure 2b). Strands β5 and β11, helix α5 and
four separate loop structures all contribute residues to the
active site of the enzyme.
Major topological differences between PNP and MTAP
occur at the N and C termini of the polypeptide chain. The
first ordered residues at the N terminus of MTAP belong
to strand β1. As the residues Met1–Thr8 in MTAP appear
to be disordered in the crystal structure, it is unlikely that
these N-terminal residues participate in forming an addi-
tional α helix or β strand. In PNP, however, there is an
11-residue N-terminal α helix which is connected by a loop
to the first β strand. MTAP also contains an additional
12-residue C-terminal α helix (α6) which is not present in
PNP. The location of this helix positions Leu279 of one
subunit near the hydrophobic 5′-methylthio-binding
pocket of a neighboring subunit in the trimer.
The only major break in the electron density occurs in the
loop between β11 and α5 and involves residues Lys225,
Glu226, His227, Glu228 and Glu229. This flexible loop is
believed to extend out away from the trimer into a large
solvent channel of the crystal, and the missing density in
this region probably results from disorder. The N terminus
also extends into a solvent channel, and due to the poor
electron density in this region eight native N-terminal
residues and three residual polyhistidine-tag residues are
also missing from the final model.
The crystal structure reveals that human MTAP is a trimer
containing three identical subunits related by C3 symmetry.
The enzyme is positioned in the cell such that the molecular
threefold axis of the trimer is along a crystallographic three-
fold axis. The trimer measures ~35 Å along the axis and
~75 Å across. There are few contacts between trimers in the
crystal, and consequently the majority of the trimer surface
is exposed to solvent channels which make up 59% of the
cell volume. The subunit contacts within a trimer are more
extensive and primarily involve residues from strand β7 and
the loop connecting β7 to helix α2 of one subunit, and helix
α3 and the loop connecting strand β9 to α3 of a neighboring
subunit. At the trimer interface, direct contacts between
identical residues related by the threefold axis include a
hydrophobic interaction of three Trp189 residues and a
hydrogen-bond network involving three Thr118 residues.
The active site
The active site of each monomer is located near the inter-
face between subunits. Figure 3 illustrates the MTAP
trimer and the location of the three active sites. In MTAP,
the active site of a given subunit is composed entirely of
residues from that subunit with the exception of His137
and Leu279, which belong to a neighboring subunit. This
trimeric arrangement of subunits is very similar to that
seen in mammalian PNP [13,14].
Although no substrates or inhibitors of MTAP were
added during the purification or crystallization of the
enzyme, the MAD-phased electron-density maps
revealed strong planar density in the purine-binding site.
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Figure 1
Example of the experimental electron density.
Stereoview of the solvent-flattened
experimental map calculated using MAD
phases to 2.2 Å resolution showing a
representative section of the model. The map
is contoured at the 1σ level and superimposed
on the refined models. (The figure was
produced using the program CHAIN [40].) 
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Structure
This density persisted throughout refinement against the
native diffraction data, and an adenine molecule was
eventually included in this region of the model. Several
hydrogen bonds are possible between the adenine base
and sidechain atoms, which offers further support for the
presence of the purine and allows us to identify key
residues that account for base specificity.
Diffraction data were also collected on a native MTAP
crystal soaked in MTA and ammonium sulfate. MTA is
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Structure of the MTAP monomer. (a) Ribbon representation of the
secondary structure elements in the human MTAP monomer:
β strands, labeled β1–β11, are represented by flat green arrows and
α helices, labeled α1–α6, are colored magenta. Regions of random
coil are shown in blue and the two turns of 310 helix are colored cyan.
The short yellow loop between β11 and α5 represents residues
225–229, which are missing in the final model. The refined positions of
MTA and sulfate are represented by ball-and-stick models with atoms
color-coded: red, oxygen atoms; blue, nitrogen atoms; gray, carbon
atoms; and yellow, sulfur atoms. The N and C termini are labeled.
(b) Topology diagram of the β-sheet structure in the MTAP monomer:
β strands are represented by arrows and α helices by cylinders.
Secondary structure elements are labeled accordingly, as in (a). The
first and last residues in the β strands and α helices are also identified.
(The figure was produced using Microsoft PowerPoint [Microsoft
Corporation, Redmond, WA].) (c) Stereoview Cα trace of an MTAP
subunit. Every twentieth residue is labeled. The broken line represents
the disordered loop containing residues 225–229. MTA and sulfate
are modeled in red. (The figure was produced using the program
MOLSCRIPT [41].)
the natural nucleoside substrate for the enzyme and
should bind in the active site. Sulfate was chosen as a
phosphate substitute on the basis that the two molecules
share similar chemical characteristics and that sulfate is an
inhibitor of the catalytic reaction. The putative phos-
phate-binding site will be referred to as the sulfate/phos-
phate-binding site hereafter, in consideration of the fact
that important structural information about this region of
the active site is obtained based on the structure of the
sulfate-containing crystal.
Although difference density is strong for the sulfate ion
and nucleoside base, the density for the nucleoside sugar
moiety is not as clearly defined. This could be due to
increased flexibility of the ribose unit, but is more likely
to be a result of low occupancy indicating that MTA may
not have fully displaced the adenine during the crystal-
soaking experiment. Although the difference density for
the methylthioribose group was not as strong as the
density for the sulfate ion and base, a reliable model for
the methylthioriobosyl group could be easily built.
The active site of MTAP contains three distinct regions
corresponding to the base-, methylthioribose- and
sulfate/phosphate-binding sites. Figure 4a shows the ori-
entation of the ligands with respect to important active-
site residues. The geometric arrangement of the
sulfate/phosphate- and nucleoside-binding sites places the
sulfate ion on the α face of the ribose of MTA. Active-site
residues position the sulfate ion such that O4 is 4.06 Å
away from C1′ of the nucleoside. MTA is modeled with a
glycosidic torsion angle (O4′–C1′–N9–C4) of 126° and a
C4′-endo sugar pucker for the methylthioribose moiety.
This is an unusual conformation compared to purine
nucleosides in solution, which generally have a glycosidic
torsion angle near 0° (syn) or 180° (anti) [22]. Crystallo-
graphic analysis of PNP in complex with various nucleo-
sides and nucleoside analogs reveals an average glycosidic
torsion angle of 145° [16], which suggests that MTAP and
PNP bind nucleosides in a similar manner. Figure 4b
shows a schematic representation of the ligands bound in
the active site.
The base-binding site
The electron density reveals that Phe177, Ser178, Asp220,
Asp222 and a water molecule facilitate the binding of the
purine base. Extensive hydrogen bonding between the
enzyme and ligand in this region of the active site pro-
vides specificity for 6-aminopurine nucleosides. If Asp220
in MTAP is protonated (see later section), then the dis-
tance between Asp220 OD1 and N7 of adenine (2.97 Å)
suggests a hydrogen bond. It appears that Asp220 can also
form hydrogen bonds with N6 of adenine and the back-
bone nitrogen of Asp222. A hydrogen bond between
Asp220 OD2 and Asp222 N may contribute to the ability
of Asp222 to adopt an unfavorable φ/ψ (53°/–121°) confor-
mation. Asp222 can form a weak hydrogen bond with N6
of adenine while also participating in a hydrogen-bond
network with a water molecule, Ser178 OG and Ser178 N.
This set of interactions orients the water molecule cor-
rectly so that it can donate a hydrogen bond to the unpro-
tonated N1 of adenine. The plane of the phenyl group of
Phe177 is nearly perpendicular to the plane of the purine
ring system, generating a herringbone-type base-stacking
interaction between the enzyme and the base.
The methylthioribose-binding site
Met196, Val233, Val236 and Leu237 in addition to His237
and Leu279 from a neighboring subunit are present in the
methylthioribose-binding pocket of MTAP. The enzyme
appears to form only one hydrogen bond with the sugar
moiety of MTA. The amide nitrogen of Met196 is a rea-
sonable hydrogen-bonding distance (3.06 Å) from the
2′-hydroxyl of the ribose ring. Val233, Val236 and Leu237
together with Leu279 from a neighboring subunit form a
hydrophobic pocket near the 5′-methylthio group of
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Figure 3
Stereoview of the MTAP trimer. The trimer is
viewed down the molecular/crystallographic
threefold axis. Each subunit is shown in a
different color, with MTA and sulfate modeled
in red in each of the three active sites.
Broken lines indicate residues 225–229,
which are missing in the final model. (The
figure was produced using the program
MOLSCRIPT [41].)
Structure
MTA. The face of the imidazole ring of His137 from a
neighboring subunit also packs against the 5′ region of the
ribose moiety.
The sulfate/phosphate-binding site
The sulfate/phosphate-binding pocket contains Thr18,
Arg60, His61, Thr93, Ala94 and Thr197. These residues
contribute a complement of sidechain and backbone
atoms that facilitate the binding of a negatively charged
ion. The positively charged guanidinium group of Arg60
provides a favorable charge–charge interaction with the
sulfate ion. In addition, Thr18 OG1, Thr93 OG1, Thr197
OG1 and His61 NE2 form hydrogen bonds with the
oxygen atoms of sulfate. The amide nitrogens of Thr18
and Ala94 also donate hydrogen bonds to one of the
sulfate oxygens. The conformation of Thr18 is different in
the two MTAP structures, suggesting that the Thr18
sidechain may undergo a conformational change upon
sulfate/phosphate binding.
Comparisons to human PNP
The high degree of structural homology between MTAP
and PNP is not readily apparent from primary sequence
data. Sequence alignments alone reveal that MTAP shares
approximately 28% identity with bovine PNP and about
27% identity with human PNP. However, the similar
functions suggest, and the highly conserved topology
demonstrates, that they are homologous proteins. A struc-
tural alignment of MTAP to human and bovine PNP
(Figure 5) reveals a similar geometric arrangement of the
nucleoside- and phosphate-binding sites, as well as a
similar overall active-site architecture. An alignment of the
protein sequences based on regions of structural homology
(Figure 5) highlights several key residue changes that may
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Figure 4
The MTAP active site. (a) Stereoview of the
active site showing key residues. MTA and
sulfate are colored magenta and are labeled
accordingly. Active-site residues from one
monomer are in yellow, and residues from the
neighboring monomer are colored cyan. The
blue sphere represents the active-site water
molecule. (The figure was made using the
program RIBBONS [42].) (b) Schematic
representation of the MTAP active site.
Residues of MTAP are shown boxed and
labeled appropriately. Shaded residues identify
structurally equivalent residues in PNP. An
asterisk is used to denote an active-site residue
contributed from a neighboring monomer.
Dotted lines indicate proposed protein–protein
or protein–ligand hydrogen bonds. (The figure
was produced using CHEMDRAW
[CambridgeSoft, Cambridge, MA].)
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Structure
account for the differences in substrate specificity
between MTAP and PNP.
Base specificity
In MTAP, Asp220 appears to have an important role in
nucleobase specificity by acting as both a hydrogen-bond
donor to N7 and a hydrogen-bond acceptor for N6 of
adenine. In PNP, Asp220 is replaced by Asn243. This
change is reasonable considering the fact that PNP is spe-
cific for 6-oxopurines and therefore requires a good hydro-
gen-bond donor for both N7 and O6 of the base, a task
well suited to the amino group of Asn243. Interestingly, it
has been shown that mutating Asn243 to an alanine in
human PNP results in a 470-fold decrease in catalytic effi-
ciency, which is primarily due to a 1000-fold decrease in
kcat [15]. This observation suggests that Asn243 is also an
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Figure 5
Structural alignment and structure-based
sequence comparison of MTAP and PNP.
(a) Stereoview of the structural alignment of
human MTAP (red), human PNP (cyan), and
bovine PNP (yellow). Only the Cα trace for a
single subunit of each enzyme is shown. MTA
and sulfate are modeled in black stick form to
indicate the active-site location. (b) The
structure-based sequence alignment of the
three enzymes. Residues with similar
properties are shaded in gray and identical
residues are denoted by black arrowheads.
Secondary structure elements are
represented by arrows (β strands) and
cylinders (α helices) for both MTAP (above
the alignment in black) and human PNP
(below the alignment in gray). Active-site
residues are highlighted in magenta
(phosphate-binding site), green (sugar-binding
site) and cyan (base-binding site). Numbers
indicate every tenth residue based on the
MTAP sequence. (The figure was made using
the program ALSCRIPT [43].)
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important catalytic residue. The ability of a nucleoside
phosphorylase to achieve such a significant change in base
specificity by replacing a catalytically important residue
without losing functionality and still maintaining the same
overall active-site architecture has been demonstrated (see
later section) [17].
Asp222 in MTAP can form a weak hydrogen bond with
N6 of adenine and can participate along with Ser178 in the
positioning of a water molecule to act as a hydrogen-bond
donor to N1, which is not protonated in 6-aminopurines.
PNP utilizes Glu201 in place of Ser178 and the active site
water molecule of MTAP, thus providing a good hydro-
gen-bond acceptor for N1, which is protonated in 6-oxo-
purines. MTAP and PNP both utilize an active-site
phenylalanine residue (Phe177 and Phe200, respectively),
which can provide a herringbone stacking interaction with
the purine ring of either 6-aminopurine or 6-oxopurine
nucleoside substrates.
Sugar specificity
A comparison of residues in the ribose-binding site reveals
another significant difference between MTAP and PNP
that may account for the altered substrate specificity. The
affinity of MTAP for 5′-deoxynucleosides and nucleosides
with a halogen, haloalkyl or alkylthio group at the 5′ posi-
tion appears to result from the general hydrophobicity and
complete lack of hydrogen-bond donors or acceptors in this
region of the active site. In PNP, His257 occupies the same
position as Val233 in MTAP and appears to form a hydro-
gen bond with the 5′-hydroxyl group of guanosine and
inosine. The smaller alkyl sidechain of Val233 in MTAP
may provide a more suitable environment for nucleosides
with larger hydrophobic groups at the 5′ position.
His137 of MTAP and Phe159 of PNP are both con-
tributed by a neighboring subunit and occupy nearly iden-
tical positions in the ribose-binding site of their respective
enzymes. The face of the ring system in both His137 and
Phe159 packs against the 5′ region of the nucleoside sub-
strate, and probably forms van der Waals contacts with the
ribose moiety. In addition to contributing to the active site
of a neighboring subunit, His137 in MTAP also hydrogen
bonds to a water molecule, which in turn is hydrogen
bonded to His65 of the neighboring subunit. This hydro-
gen-bonding scheme may represent an important
subunit–subunit interaction in the MTAP trimer.
Sulfate/phosphate binding 
Comparisons of the residues involved in sulfate/phosphate
binding in MTAP and PNP reveal the highest conserva-
tion of functional groups compared to the other active-site
regions. The two serine residues involved in sulfate/phos-
phate binding in PNP, Ser33 and Ser220, are replaced by
Thr18 and Thr197 in MTAP. MTAP also contains 
an additional sulfate/phosphate-binding residue, Thr93.
Asn115 occupies this region in PNP, but the structure
reveals that the sidechain points away from the phos-
phate-binding pocket. The arginine residue in the
sulfate/phosphate-binding region of MTAP (Arg60) is
structurally conserved in PNP (Arg84), suggesting that
mammalian PNP and MTAP might utilize this residue in
a similar fashion for substrate binding and catalysis.
Although His61 in MTAP and His86 in PNP appear to
have similar roles in sulfate/phosphate binding, there is a
difference in the backbone structure of the two enzymes
in this region of the active site. The structural alignment
places the Cα atoms for the two histidine residues nearly
7 Å apart. The sidechain conformations for the respective
histidines, however, result in a much closer alignment of
the imidazole rings, which provide the interaction with the
sulfate/phosphate ion.
Implications for catalysis
Given the similar function and overall conserved active-
site architecture of MTAP and PNP, it is likely that these
enzymes share a common catalytic mechanism. The PNP
reaction is believed to proceed through an SN1-type mech-
anism in which the glycosidic bond is cleaved first forming
an oxocarbenium intermediate [16]. The oxocarbenium
ion is then stabilized and subsequently attacked by a nega-
tively charged phosphate oxygen. Crystallographic studies
of human PNP bound to 6-oxopurine nucleosides reveal
that the carboxamido group of Asn243 is in a good position
to stabilize the transition-state structure by donating a
hydrogen bond to N7 of the purine. The biochemical evi-
dence obtained from the Asn243→Ala mutant discussed
above also supports this important role for Asn243 in catal-
ysis. A large decrease in catalytic efficiency for a
Glu201→Ala mutant of PNP revealed that this residue
also has a role in catalysis, although the primary factor was
a large increase in Km for the nucleoside substrate [16].
The PNP structure shows that in the phosphate-binding
site, His86 hydrogen bonds to phosphate and to the car-
boxyl group of Glu89. The orientation of Glu89, His86 and
phosphate is similar to the catalytic triad seen in the serine
proteases [23]. This arrangement of functional groups may
act to increase the nucleophilicity of the phosphate.
Structural analysis suggests that MTAP may utilize a
similar reaction mechanism. MTAP, like PNP, binds
β-nucleosides in a high-energy C4′-endo conformation,
which is believed to put strain on the substrate and may
help weaken the glycosidic bond. The sulfate/phosphate-
binding site of MTAP positions the sulfate ion on the
α face of the MTA ribose moiety. The closest sulfate
oxygen in the MTAP structure, O4, is 4.06 Å away from
C1′ of the nucleoside, and is in a good position to initially
stabilize the partial positive charge on O4′ of the proposed
oxocarbenium ion intermediate. It is conceivable that a
conformational change in MTAP during the reaction
brings the phosphate oxygen into closer proximity to the
636 Structure 1999, Vol 7 No 6
electrophilic C1′ allowing for the subsequent nucleophilic
attack. It has been shown that a buried aspartic acid
residue can exhibit a significant increase in pKa allowing it
to be protonated under normal physiological conditions
(~pH 7) [24]. If Asp220 in MTAP is protonated, this
residue is in an excellent position to protonate N7 of the
purine in order to accommodate the flow of negative
charge to the base that occurs during glycosidic bond
cleavage (Figure 6). The proposed hydrogen bond
between Asp220 OD2 and the backbone nitrogen of
Asp222 may have an important role in anchoring the
Asp220 sidechain so that Asp220 OD1 is in a good position
to protonate N7 of the purine during catalysis. Thus, it
appears that in addition to contributing to the specificity
for 6-aminopurines, Asp220 and Asp222 in MTAP may
also help to conserve the catalytic mechanism proposed
for mammalian PNP.
The ability of a protonated aspartic acid residue to assist in
the enzyme-catalyzed phosphorolysis of nucleosides was
predicted following a mutational study on human PNP in
which Asn243 was mutated to an aspartic acid residue
[17]. The Asn243→Asp mutant displayed a lower affinity
for inosine and guanosine in addition to a decrease in kcat
relative to wild-type PNP. In contrast, adenosine was a
good substrate for the mutant and revealed a 5000-fold
increase in kcat when compared to the rate of phosphoro-
lysis of adenosine by wild-type PNP. The catalytic effi-
ciency of the mutant utilizing adenosine as a substrate was
only 80-fold lower than the catalytic efficiency of wild-
type PNP with its natural substrate, inosine. This single
mutation resulted in an enzyme that exhibits a change in
substrate specificity from 6-oxopurine to 6-aminopurine
nucleosides, but retains the ability to efficiently catalyze
cleavage of the glycosidic bond.
Replacing the catalytically important Glu201 in PNP with
the Asp222–Ser178–water network of interactions in
MTAP accommodates the unprotonated N1 of the
6-aminopurine while conserving catalytic efficiency. It is
believed that Glu201 in PNP offers specificity for 6-oxo-
purines and helps to hold the nucleoside in a catalytically
competent orientation, which is reflected by the large
change in Km and smaller change in kcat of the
Glu201→Ala PNP mutant [15,16]. Therefore, the changes
in this region of the active site of MTAP to accommodate
the 6-aminopurine are not expected to cause significant
alterations in the catalytic mechanism. The functionally
conserved His86 in PNP and His61 in MTAP appear to
have similar roles in phosphate binding. Unlike the
Glu89-His86-phosphate triad that is seen in the PNP
structure, His61 in MTAP hydrogen bonds to a backbone
carbonyl oxygen rather than an acidic group. Furthermore,
the Glu89→Ala mutation in PNP did not have a large
effect on catalytic activity. These results suggest that a
catalytic triad is not required for efficient glycosidic bond
cleavage in MTAP or PNP.
Biological implications
Human 5′-deoxy-5′-methylthioadenosine phosphorylase
(MTAP) functions in the purine salvage pathway where
it catalyzes the reversible phosphorolysis of 5′-deoxy-5′-
methythioadenosine (MTA). We report here the crystal
structure of human MTAP. Structural comparisons
reveal that the enzyme is a member of the mammalian
purine nucleoside phosphorylase (PNP) family of
trimeric enzymes, which contain a unique α/β fold. Struc-
tural studies of MTAP bound to adenine and in complex
with MTA and sulfate have identified important active-
site residues. A detailed view of the MTAP active site
confirms the functional similarities of MTAP and PNP,
while also providing insight into the structural changes
required for the differences in substrate specificity
between the two enzymes. Analysis of the MTAP struc-
ture also suggests that the previously proposed catalytic
mechanism for PNP can be extended to MTAP as well. 
The absence of MTAP activity in several malignant
human cell lines has been reported [25]. The loss of
enzyme function in these cells is now believed to be a
result of homozygous deletions on chromosome 9 of the
closely linked MTAP and p16/MTS1 tumor suppressor
genes [26]. As the absence of the tumor suppressor is
probably responsible for the onset of malignancy, the
lack of MTAP activity appears to be a consequence of
cancer development and not a primary cause. Neverthe-
less, the absence of MTAP activity does have an impor-
tant impact on purine metabolism in these cells. It has
been shown that MTAP-deficient (MTAP–) carcinoma
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Figure 6
Proposed transition-state structure for the enzyme-catalyzed
phosphorolysis of MTA. (The figure was produced using CHEMDRAW
[CambridgeSoft, Cambridge, MA].)
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cells display an increased rate of de novo purine synthe-
sis, when compared to the same cells transfected with
and expressing MTAP cDNA [27]. These results
suggest that in the absence of MTAP activity, cells
cannot recycle adenine back into nucleotides and must
therefore increase their rate of de novo AMP synthesis.
An important consequence of this finding is that the
MTAP– cells should be more susceptible to the growth
inhibitory effects of chemotherapeutic drugs that specifi-
cally target the purine biosynthetic pathway. In fact,
MTAP– cancer cell lines do display increased sensitivity
towards methotrexate and azaserine in the presence of
MTA, whereas cancer cell lines with MTAP activity
(MTAP+ cells) were not as severely affected [27,28]. In
view of these observations, it may be possible to enhance
the treatment of MTAP+ tumors by the co-administra-
tion of strong MTAP inhibitors together with traditional
chemotherapeutic compounds that specifically target the
de novo purine biosynthetic machinery. The structure of
MTAP provides a detailed view of the active site and
offers insight into the roles that specific residues play in
substrate binding and catalysis. This information will
assist in the identification and design of strong inhibitors
of MTAP should the enzyme prove to be a useful
chemotherapeutic target.
Materials and methods
Unless otherwise noted, all chemicals and reagents were purchased
from the Sigma Chemical Company, St Louis, MO.
Expression and purification of native MTAP
MTAP cDNA isolated from a human placenta cDNA gene library was
amplified using the polymerase chain reaction (PCR) and cloned into
the expression vector pKK223 (K Takabayashi and MDE, unpublished
results). The MTAP cDNA was then subcloned into the pET-28a expres-
sion vector [Novagen Inc.] using traditional molecular cloning tech-
niques. This new expression construct, which codes for an N-terminal
thrombin-cleavable polyhistidine-tag, was subsequently transformed into
E. coli BL21(DE3) cells [Novagen Inc.]. Induction cultures containing
1 L of Luria broth (LB) media and 30 µg/ml of kanamycin were inocu-
lated with 1 ml saturated starter-cultures and incubated at 37°C. When
the induction cultures reached an OD600 of ~0.6, the cells were
induced with 1 mM isopropyl-β-D-thiogalactopyranoside (IPTG) for 4 h
at 37°C. Cells were harvested by centrifugation and resuspended in
40 ml ice cold binding buffer (5 mM imidazole, 500 mM NaCl, 20 mM
Tris-HCl pH 7.9) [Novagen Inc.]. All subsequent protein purification
steps were carried out at 4°C or on ice. Cells were lysed using a French
press followed by sonication. Following a high-speed centrifugation step
to remove insoluble material, the clarified cell extract was filtered and
applied to a 2.5 ml HisBind immobilized nickel column [Novagen Inc.],
which was previously equilibrated with binding buffer. The column was
washed with ten volumes of binding buffer followed by six volumes of
wash buffer (60 mM imidazole, 500 mM NaCl, 20 mM Tris-HCl pH 7.9)
[Novagen Inc.]. 6His–MTAP was eluted with six volumes of 300 mM imi-
dazole, 500 mM NaCl and 20 mM Tris-HCl pH 7.9. The protein solution
was then buffer-exchanged into 20 mM Tris-HCl pH 8.4, 150 mM NaCl,
2.5 mM CaCl2 and 2 mM dithiothreitol (DTT) using an ultra-filtration
device. To cleave the polyhistidine-tag, the protein solution was treated
with 0.5 U of biotinylated thrombin [Novagen Inc.] per mg of 6His–MTAP
at 4°C for ~16 h. The reaction mixture was then passed over a strepta-
vidin agarose column [Novagen Inc.] to remove the biotinylated pro-
tease. The protein solution was buffer-exchanged back into binding
buffer and passed over a second nickel column in order to remove the
free poly-histidine-tag. The purified MTAP was buffer-exchanged and
subsequently concentrated to 23 mg/ml in 10 mM Tris-HCl pH 7.4 and
2 mM DTT. The purified material was stored at –80°C. The protein con-
centration was determined by the Bradford method [29] using protein
assay dye reagent (BioRad) with bovine serum albumin as a standard.
Purity was verified by running samples on a 12% polyacrylamide gel fol-
lowed by Coomassie staining (data not shown). Spectrophotometric
MTAP assays following the method of Toorchen and Miller [10] were
performed to verify enzyme activity.
Expression and purification of SeMet–MTAP
Production of SeMet–MTAP follows essentially the same protocol as
above with a few alterations. The expression host used for production
of SeMet–MTAP is the E. coli B834(DE3) methionine auxotroph
[Novagen Inc.]. The 1 L induction cultures contain M9 media supple-
mented with 40 µg/ml L-amino acids (not including methionine), 1X
BME vitamin solution (GibcoBRL), 0.4% (w/v) glucose, 2 mM MgSO4,
25 µg/ml FeSO4.7H2O, 30 µg/ml kanamycin, 0.1 mM CaCl2 and
40 µg/ml L-selenomethionine. These induction cultures were inoculated
with cells from a 1 ml saturated starter-culture containing the above
media with L-methionine in place of L-selenomethionine in order to
promote growth. The starter cells were then pelleted and washed in the
induction culture media immediately before inoculation in order to
remove as much residual L-methionine as possible. SeMet–MTAP is
also purified and stored in the presence of 5 mM DTT rather than 2 mM
DTT in order to protect against oxidation of the selenium atoms.
Crystallization of native MTAP
Initial crystallization conditions for native MTAP were determined using
the sparse matrix screens, crystal screen and crystal screen 2
(Hampton Research). Several conditions yielded crystals of varying
quality. The most promising crystals grew from condition 37 of the
crystal screen 2 kit (10% PEG 8000, 0.1 M Hepes pH 7.5, 8% ethyl-
ene glycol). Subsequent optimization of the initial conditions resulted in
diffraction-quality crystals that grow at room temperature using the
hanging-drop vapor diffusion technique. Drops (4 µl) contained a 1:1
mixture of protein and reservoir solutions. The protein solution is
described above. The reservoir solution contained 12% (w/v) PEG
6000, 25% (v/v) ethylene glycol, 200 mM Tris-HCl pH 7.4 and 2 mM
DTT. Drops were equilibrated against 1.0 ml of reservoir solution.
Crystallization of SeMet–MTAP
Diffraction-quality crystals of SeMet–MTAP were grown at room tem-
perature using the hanging-drop vapor diffusion method described
above. The protein solution contained 25 mg/ml SeMet–MTAP, 10 mM
Tris-HCl pH 7.4, 5 mM DTT and 400 mM NaCl. The reservoir solution
contained 12% (w/v) PEG 6000, 25% (v/v) ethylene glycol, 80 mM
MES pH 5.9 and 5 mM DTT.
MTA and sulfate crystal soak
Two week old native MTAP crystals were transferred from their original
hanging drops containing 12% (w/v) PEG 6000, 25% ethylene glycol,
200 mM Tris-HCl pH 7.4 and 2 mM DTT, prior to equilibration, into an
artificial mother liquor containing the above solution supplemented with
10 mM NH4SO4 and 4 mM MTA. The soaks were carried out overnight
(16 h) before crystals were looped and frozen for data collection.
MAD data (2.8 Å resolution)
A three-wavelength MAD data set was collected on a single frozen
(–180°C) SeMet–MTAP crystal on the F2 beamline at CHESS
(Cornell University, Ithaca, NY). An X-ray absorption spectrum (in the
vicinity of the Se K-absorption edge) for SeMet–MTAP was deter-
mined by recording fluorescence measurements on a solid-state
detector during an energy scan of the crystal. Diffraction data were
then collected to 2.8 Å resolution at wavelengths corresponding to
the inflection point of the spectrum (0.97938 Å), the peak of the
spectrum (0.97915 Å), and a reference wavelength above the peak
(0.96768 Å). The data were acquired on a 1K charged-couple device
(CCD) detector [30] using 1° oscillations with 30 s exposures. The
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crystal-to-detector distance was 70 mm and the detector area was
51 mm by 51 mm. In order to minimize systematic errors, Bijvoet pairs
at the different wavelengths were acquired close in time by collecting
the data in 5° wedges simulating inverse beam geometry (5° starting
at φ followed by 5° starting at φ + 180°) and alternating wavelengths
throughout the experiment until a total of 80° (40° starting at φ = 0°
and 40° starting at φ = 180°) were collected for each wavelength.
The data were processed with the program DENZO and
SCALEPACK [31]. Unmerged data output from SCALEPACK (with
the ‘NO MERGE ORIGINAL INDEX’ flag set) for all three wavelengths
were used as input for the MADSYS series of programs [20].
ANOSCL was used to perform a local scaling routine intended to min-
imize the systematic error between Bijvoet pairs, thus allowing for
accurate determination of the anomalous signal. A second local
scaling routine, WVLSCL, was then run to minimize the systematic
errors between data from different wavelengths in order to enhance
determination of the dispersive signal. MADLSQ was subsequently
used to calculate structure-factor amplitudes for the normal scattering
from all atoms in the structure (|FT|), structure-factor amplitudes for the
normal scattering from the selenium atoms alone (|FA|), and the phase
differences between the structure factors FT and FA (∆φ = φT–φA) for
the unmerged reflection data. Finally, MERGIT was run to merge the
results for multiple observations of the same reflection. The SHELXS
software package [21] was used to calculate E values based on the
FA values and direct methods were used to find eight out of the nine
selenium atom positions. The eight Se positions were used together
with data from all three wavelengths to refine heavy-atom parameters
and calculate experimental phases using the MADSYS programs
ASLSQ and MADABCD, respectively. Density modification was per-
formed using the initial phases and structure-factor amplitudes from
the reference wavelength in the program DM [32] of the CCP4 suite
[33]. DM was run in reflection omit mode with the ‘NCYCLE AUTO’
flag set. The program terminated after two cycles of solvent-flattening
and histogram matching. The figure of merit was 0.65 prior to density
modification and was 0.84 after density modification.
Data were also collected on the F1 beamline at CHESS using a native
MTAP crystal and a native MTAP crystal soaked in sulfate and MTA. Both
data sets were collected to 1.7 Å resolution on a Quantum-4 CCD detec-
tor (ADSC) using 1° oscillations until greater than 90% overall complete-
ness was observed. The Quantum-4 data sets were both indexed with
MOSFLM [34] and scaled using SCALA [35] from the CCP4 suite of
programs. Data collection statistics are summarized in Table 1.
MAD data (2.2 Å resolution) 
A higher resolution three-wavelength MAD data set was later col-
lected on a single frozen (–180°C) SeMet–MTAP crystal on the X12C
beamline at the NSLS (Brookhaven National Laboratory, Upton, NY).
As before, an absorption spectrum was determined and data were
collected at wavelengths corresponding to the inflection point
(0.97913 Å), the peak (0.97874 Å), and a reference wavelength
above the peak (0.95000 Å). The data were acquired to 2.2 Å resolu-
tion on the single-module Brandeis CCD detector using 1° oscillations
and 60 s exposures. The crystal-to-detector distance was 101.8 mm
and the detector area was 100 mm by 100 mm. This time, however,
the data set at each wavelength was collected in its entirety simulating
inverse beam geometry (30° starting at φ = 0° followed by 30° starting
at φ = 180°), before moving on to the next wavelength.
The NSLS MAD data were also processed using DENZO and
SCALEPACK. This data together with the previously determined eight
Se-atom positions was directly input into MLPHARE [36] from the
CCP4 suite of programs to refine heavy-atom parameters and calculate
experimental phases to 2.2 Å resolution. DM was run using the higher
resolution data and phases in reflection omit mode with the ‘NCYCLE
AUTO’ flag set. The program terminated after four cycles of solvent-flat-
tening and histogram matching. The figure of merit was 0.59 prior to
density modification and was 0.87 after density modification. Data col-
lection statistics are summarized in Table 1.
Model building and refinement
The interactive computer graphics program O [37] was used to build a
Cα trace for an MTAP monomer into the original 2.8 Å resolution MAD
map. Chain tracing proceeded smoothly as electron density was con-
tinuous for the majority of the molecule. Mainchain and sidechain atoms
were subsequently built into the remaining density. Electron density for
residues 129–134 and 261–265 was discontinuous and difficult to
interpret. The initial 2.8 Å resolution model did not include residues
1–9, 225–229 and the C-terminal residues 272–283, as density for
these regions of the protein was very weak or missing.
At this point it was possible to refit the 2.8 Å resolution model
according to the new 2.2 Å resolution experimental map. Well
resolved bumps in the higher resolution map, corresponding to the
carbonyl oxygens, allowed for adjustment of mainchain atom posi-
tions. Several sidechain atoms were also adjusted. Significant
improvements to the electron density in the regions of residues
129–134 and 261–265 were also evident and the positions of these
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Table 1
Summary of diffraction data.
Data type/source Se MAD (CHESS F2) Se MAD (NSLS X12C) Mono (CHESS F1)
Inflection Peak Reference Inflection Peak Reference Native Complex
Wavelength (Å) 0.97938 0.97915 0.96768 0.97913 0.97874 0.95000 0.91900 0.91900
Resolution (Å) 2.80 2.80 2.80 2.20 2.20 2.20 1.70 1.70
No. observations 41,898 41,818 42,258 69,120 67,457 69,285 276,082 393,633
No. unique 9087 9059 9083 18,938 18,924 19,026 39,479 42,292
Completeness (%) 97.7 (91.8) 97.7 (91.4) 98.2 (93.7) 99.0 (97.4) 99.0 (97.5) 99.0 (96.8) 93.1 (83.7) 96.8 (93.2)
Rsym*(%) 4.9 (7.0) 5.6 (7.8) 5.3 (8.0) 5.9 (7.8) 7.3 (9.3) 6.4 (8.1) 4.5 (7.8) 5.3 (10.6)
Average I/σI 25.8 (17.2) 22.4 (15.5) 23.6 (15.8) 18.9 (9.8) 16.7 (9.1) 17.7 (9.2) 12.4 (8.1) 9.4 (6.5)
f′ values –8.727 –8.513 –3.596 –7.814 –6.708 –2.722 – –
f′′ values 3.242 4.273 3.859 3.244 4.544 3.260 – –
Values for the outer resolution shell are given in parentheses: Cornell
High Energy Synchrotron Source (CHESS) MAD data, 2.90–2.80 Å;
National Synchrotron Light Source (NSLS) MAD data, 2.28–2.20 Å;
CHESS native data, 1.79–1.70 Å; CHESS MTAP–MTA–sulfate complex
data, 1.79–1.70 Å. *Rsym = ΣΣi |Ii–<I>|/Σ<I>, where <I> is the mean
intensity of the N reflections with intensities Ii and common indices h,k,l.
residues were modified accordingly. Previously missing mainchain
atoms and most of the sidechain atoms for residues in the C-terminal
helix and C-terminal tail up to residue 279 were also easily modeled
using the new electron-density map. Strong planar density was also
found in the region that was believed to be the purine-binding site.
Initially, this density was not modeled to see if it would persist
during refinement.
The improved initial model was refined against the 1.7 Å resolution data
from the native MTAP crystal using X-PLOR [38]. Several rounds of
simulated annealing (SA) [39] followed by manual re-fitting of the
model in the program O were performed. Refinement began using bulk-
solvent-corrected data to 2.3 Å resolution. After the data were
extended to 2.0 Å resolution, water molecules were included in the
model during subsequent rounds of refinement based on 3σ peaks in
Fo–Fc maps that contained a reasonable hydrogen bond to at least one
other protein, ligand or solvent atom. The data were eventually
extended to 1.7 Å resolution. At this point, the density in the proposed
purine-binding site was still very strong and an adenine molecule was
modeled into this region. Density for residues 280 and 281 was
revealed during refinement, but density for the N-terminal residues 1–8
(plus Gly-Ser-His from the 6His-tag), surface loop residues 225–229
and C-terminal residues 282 and 283 never appeared. The final model
includes 173 water molecules, one adenine molecule and 2068 protein
atoms from 268 of the 283 natural residues. Refinement statistics for
this model are given in Table 2.
The refined native MTAP model was then used as an initial model for
X-PLOR refinement of the MTA–sulfate crystal soak data. Data from
8.0–3.0 Å resolution were used in rigid-body refinement for an overall
adjustment of the model to fit the new data. An Fo–Fc difference electron-
density map was then calculated. Strong difference density was clearly
visible for a sulfate ion. Density near Thr18 suggested that the sidechain
was now in a different conformation. The presence of the nucleoside
base was also evident. Density for the methylthioribose portion of the
nucleoside, however, was weak and difficult to interpret. A sulfate mol-
ecule was modeled into the phosphate-binding site density, and the
sidechain of Thr18 was adjusted so that the oxygen atom fit into the new
density. Subsequent rounds of SA followed by model adjustment began
with data from 8.0–2.3 Å resolution and was eventually extended to 1.7 Å
resolution. Water molecules were added beginning at 2.0 Å resolution.
The nucleoside was left out of the model until later stages of refinement.
Refinement statistics for this model are given in Table 2.
Structure-based sequence alignment
A structural alignment of MTAP to human and bovine PNP was per-
formed by submitting the three-dimensional coordinates of each model
to the DALI server (http://www2.ebi.ac.uk/dali/). The results of the
structural alignments were verified by graphically viewing the superim-
posed molecules in the program O. Further improvements to the struc-
ture alignments were made using the LSQ program in O. The MTAP
protein sequence was then manually aligned to the bovine and human
PNP protein sequences based on the observed structural homology
between the MTAP and PNP structures.
Accession numbers
The atomic coordinates for the MTAP–adenine and MTAP–MTA–sulfate
models have been deposited in the Protein Data Bank with accession
numbers 1cb0 and 1cg6, respectively.
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Table 2
Refinement statistics and model quality.
Native MTA–sulfate
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